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We thank professor Boyages for his insightful comments. We certainly agree with his 
consideration that urinary iodine measurements currently have no place in clinical practice and 
his view on iodine supplementation. We also agree with the majority of the methodological 
concerns that were raised, however, we will explain why we believe it is unlikely that this leads 
to an overestimation of our findings.  
On several occasions, the author refers to measurement error. First of all, it is well-recognized 
that the urinary iodine concentration (UIC) is not an appropriate marker for individual iodine 
status (as is mentioned as a limitation in our paper). However, the UIC is still a useful 
measurement for population studies because the median spot UIC is a valid reflection for a large 
group of individuals. This is mainly because differences iodine intake across a population would 
shift the UIC curve, and when the median is calculated, the outskirts of day-to-day variations are 
practically balanced-out against each other. In our study, we were able to estimate the population 
or group-iodine status with adequate precision (1). Second, we agree that correcting the UIC for 
creatinine (UI/Creat) is a valid alternative to the 24-hour urinary iodine excretion when used in 
homogenous population groups (2). Third, the author questioned whether aggregating IQ scores 
is a valid approach. IQ scores are, per definition, population-standardized s ores (typically with a 
mean of 100 and a standard deviation of 15) and thus to a certain extent interchangeable between 
populations. We acknowledge that in our study especially verbal abilities was assessed using 
different methodologies (i.e., parental questionnaire versus interviews) and at different ages (i.e., 
pre-school versus school age). However, effect estimates across the different cohorts were 
similar and a sensitivity analysis in older children only (e.g., excluding the Dutch cohort), 
resulted in similar findings. In summary, we cannot deal with variations in the day-to-day iodine 
intake, but we dealt with the differences in measurement techniques (standardizing IQ scores, 
using certified reference materials, random effect models) as well as renal excretion and urine 
dilution (creatinine adjustment) to the best of our abilities. However, we believe that we do not 
overestimate our findings as actually the contrary can be expected. Measurement error of the 
exposure will bias effect estimates to the null while measurement error of a continuous outcome 
will widen effect estimate confidence intervals and decrease statistical significance (3). 
For a large group of pregnant women, a median UIC <150 µg/L is classified as iodine deficiency 
(4), mild-to-moderate iodine deficiency is typically defined as a median UIC of 50-150 µg/L and 
iodine excess is typically defined as a UIC >500 µg/L (these cut-offs differ from those in school 
children)(4,5). Regardless of specific cut-offs, categorization of continuous data causes 
methodological issues (6). Therefore, the main analyses were performed using the UI/Creat as a 
continuous variable. Any effect estimates for UI/Creat values within the group of women with a 
UI/Creat <150 µg/g can be directly extrapolated from the graphs presented in the manuscript. 
The use of flexible modeling and various sensitivity analyses excludes that skewness of the data 
caused by values above 300 µg/g affected would affect our results. Although we had incomplete 
data on iodine supplement use in two of the three cohorts (7), high values of the UI/Creat in our 
study population do not necessarily reflect iodine supplement use. For example, it is unlikely that 
British pregnant women in the early 1990s would have taken iodine-containing supplements as 
there was, and still is, no legislation concerning iodine nutrition in the UK.  
It should be noted that the TSH and FT4 concentrations displayed in Table 1 were measured 
using different assays and are therefore not comparable. Nonetheless, we are also intrigued by 
the paradoxical findings that in our study, and in the majority of studies in pregnant women, 
there is no association of UIC or iodine supplementation with TSH or FT4 concentrations (8). 
One possible reason for the lack of association could be the fact that a single measurement of 
UI/Creat does not reflect the duration of iodine deficiency. Since thyroidal iodine stores act as a 
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buffer and are expected to store enough iodine for roughly 3 months of thyroid hormone 
production, an association of UI/Creat with TSH or FT4 can perhaps only be expected to occur in 
women with a stable (low) iodine intake. In a similar fashion as described above, measurement 
error will occur in those with fluctuating iodine intake (i.e., the majority of women) and 
regression of the effect estimate to the null would cause false-negative results. A pathway that is 
much less affected by this physiology is that of fetal thyroid hormone production. The fetal 
thyroid incorporates iodine from 14 weeks onwards and provides at least 50-70% of fetal thyroid 
hormone concentrations. Therefore, even if maternal thyroid function is not affected by mild-to-
moderate iodine deficiency during pregnancy, it is still very well possible that the link of low 
maternal iodine availability with child IQ is mediated through a thyroidal pathway. 
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